Sage Journals: Discover world-class research

Abstract

Purpose:

This study assessed patients’ comprehension of the Advair and Serevent medication guides (MGs) and MG reading behaviors with the goal to improve risk communication.

Methods:

After reading their assigned MGs, 452 adults with asthma or chronic obstructive pulmonary disease participated in structured interviews to assess comprehension of safety risks in the Advair MG (asthma, n = 150; chronic obstructive pulmonary disease, n = 153) and Serevent MG (asthma, n = 149). Generalized estimating equations for correlated binary data were used to identify factors associated with correct responses.

Results:

For 10 of 12 individual risk questions, ≥75% of patients reported correct responses. After adjusting for patient characteristics, health literacy was significantly associated with correct responses (odds ratio = 1.03, 95% confidence interval = 1.02-1.05 per 1-point increase in the Rapid Estimate of Adult Literacy in Medicine). MG reading behaviors were inconsistent, with many patients reading MGs only once (40%) despite multiple prescriptions.

Conclusions:

Comprehension of safety risks in the Advair and Serevent MGs was adequate for most patients in the study but decreased with health literacy. Initiatives to improve patient-directed risk communication should consider health literacy and reasons for inconsistent reading behaviors.

Keywords

health literacy comprehension medication guide asthma chronic obstructive pulmonary disease

Get full access to this article

View all access options for this article.

References

FDA. Medication guides: distribution requirements and inclusion in risk evaluation and mitigation strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM244570.pdf. Accessed October 24, 2013.

Wolf

Davis

Shrank

Neuberger

Parker

. A critical review of FDA-approved medication guides. Patient Educ Couns. 2006;62:316–322.

Wolf

King

Wilson

. Usability of FDA-approved medication guides. J Gen Intern Med. 2012;27:1714–1720.

Shiffman

Gerlach

Sembower

Rohay

. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45:452–458.

Dusetzina

Higashi

Dorsey

. Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care. 2012;50:466–478.

FDA. Serevent Diskus medication guide. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089125.pdf. Accessed October 24, 2013.

FDA. Advair Diskus medication guide. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111326.pdf. Accessed October 24, 2013.

FDA. Drug safety communication: new safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. Accessed October 24, 2013.

ISPE. Guidelines for good pharmacoepidemilogical practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17:200–208.

10.

Davis

Long

Jackson

. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25:391–395.

11.

FDA. Guidance for industry label comprehension studies for nonprescription drug products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM143834.pdf. Accessed October 24, 2013.

12.

Zeger

Liang

Self

. The analysis of binary longitudinal data with time independent covariates. Biometrika. 1985;72:31–38.

13.

Doak

Root

. Teaching Patients With Low Literacy Skills. 2nd ed. Philadelphia, PA: Lippincott; 1996.

14.

Wolf

Davis

Bass

. Improving prescription drug warnings to promote patient comprehension [Erratum in: Arch Intern Med. 2010;170:608]. Arch Intern Med. 2010;170:50–56.

15.

Allen LaPointe

Pappas

Deverka

Anstrom

. Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions. J Gen Intern Med. 2007;22:98–101.

16.

You

Grobman

Davis

Curtis

Bailey

Wolf

. Improving pregnancy drug warnings to promote patient comprehension. Am J Obstet Gynecol. 2011;204:318.e1–318.e5.

17.

Disantostefano

Yeakey

Raphiou

Stempel

. An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005-2011. J Asthma. 2013;50:776–782.

18.

Davis

Federman

Bass

3rd . Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24:57–62.

19.

Rosas-Salazar

Apter

Canino

Celedón

. Health literacy and asthma. J Allergy Clin Immunol. 2012;129:935–942.

20.

Apter

Wan

Reisine

. The association of health literacy with adherence and outcomes in moderate-severe asthma. J Allergy Clin Immunol. 2013;132:321–327.

21.

Federman

Wolf

Sofianou

. Asthma outcomes are poor among older adults with low health literacy [published online October 8, 2013]. J Asthma.

22.

Roberts

Ghiassi

Partridge

. Health literacy in COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:499–507.

23.

Miller

Schmitt

Allison

Cobaugh

Ray

Saag

. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Ann Pharmacother. 2010;44:274–284.

24.

Enger

Younus

Petronis

Gately

Seeger

. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey. Pharmacoepidemiol Drug Saf. 2013;22:705–715.

25.

Dal Pan

. Commentary on “The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey” by Enger et al. Pharmacoepidemiol Drug Saf. 2013;22:716–718.

26.

Papay

Fritz

Catu

Ellis

Debussey

. Assessment of a simplified format of written patient prescription drug information. Drug Inf J. 2010;44:375–391.

27.

Aker

Beck

Papay

. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Ther Innov Regul Sci. 2013;47:125–132.

28.

Katz

Kripalani

Weiss

. Use of pictorial aids in medication instructions: a review of the literature. Am J Health Syst Pharm. 2006;63:2391–2397.

29.

Schillinger

Piette

Grumbach

. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163:83–90.

30.

US Department of Education. The health literacy of America’s adults: results from the 2003 national assessment of adult literacy. http://nces.ed.gov/pubs2006/2006483.pdf. Accessed October 24, 2013.

31.

Brookings Institution, Engelberg Center for Health Care Reform. Patient medication information. http://www.brookings.edu/about/centers/health/projects/pmi. Accessed October 24, 2013.

32.

Barlas

. Pharmacy provisions of health care legislation are still viable: industry’s agenda is clear, but its future path is not. P T. 2010;35:142–157.

33.

US Food and Drug Administration. Risk evaluation and mitigation strategy (REMS) assessments: social science methodologies to assess goals related to knowledge. http://www.fda.gov/Drugs/NewsEvents/ucm292337.htm. Accessed October 24, 2013.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.44 MB

14.09 MB

Patient Comprehension of Medication Guides for Asthma and Chronic Obstructive Pulmonary Disease Medications

Abstract

Purpose:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References

Supplementary Material